Last Name


Search Results to Philip Bonomi

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following items that are connected to Bonomi, Philip

Item TypeName
Concept Protein Kinase C beta
Concept Protein-Tyrosine Kinases
Concept Protein Kinase C
Concept Calcium-Calmodulin-Dependent Protein Kinases
Concept Death-Associated Protein Kinases
Concept Protein Kinase Inhibitors
Concept Receptor Protein-Tyrosine Kinases
Concept src-Family Kinases
Concept Creatine Kinase
Concept Phosphatidylinositol 3-Kinases
Concept Cyclin-Dependent Kinase Inhibitor p16
Concept Class I Phosphatidylinositol 3-Kinases
Academic Article PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.
Academic Article CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients.
Academic Article Elevated creatine phosphokinase MB in a patient with neuroendocrine carcinoma of the colon--evidence for a tumor marker. Report of a case.
Academic Article Clinical studies with non-iressa EGFR tyrosine kinase inhibitors.
Academic Article The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib.
Academic Article Selecting patients for treatment with epidermal growth factor tyrosine kinase inhibitors.
Academic Article Primary and secondary therapeutic strategies for EGF receptor pathway inhibition in non-small-cell lung cancer.
Academic Article PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy.
Academic Article A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer.
Academic Article Lyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cells.
Academic Article An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC).
Academic Article The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients.
Academic Article EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes.
Academic Article Prognostic performance of proteomic testing in advanced non-small cell lung cancer: a systematic literature review and meta-analysis.
Academic Article Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy.

Search Criteria
  • Phosphotransferases